HYPOPARATHYROIDISM

This trial tested whether a daily injection called TransCon PTH could help adults with hypoparathyroidism better control their blood calcium levels. For the first 26 weeks, some participants received the real injection while others received a placebo, and neither they nor their d…

This study followed 90 adults in Greece with chronic hypoparathyroidism, a condition where the body struggles to regulate calcium. It tested a new drug called palopegteriparatide to see if it could effectively control the disease and allow patients to stop taking daily calcium an…

This study tested whether a daily injection of a hormone called TransCon PTH could help adults with hypoparathyroidism. The goal was to see if the treatment could help patients maintain normal calcium levels in their blood while stopping or reducing their need for high-dose vitam…

This study tested a new weekly injection called MBX 2109 for adults with hypoparathyroidism, a condition where the body struggles to control calcium levels. The goal was to see if this hormone replacement could safely maintain normal calcium without requiring high doses of daily …

This study tested if delivering a replacement hormone (PTH) through a small, wearable insulin pump is better than twice-daily injections for people with chronic hypoparathyroidism. This rare condition makes it hard for the body to regulate calcium. Researchers wanted to see if th…

This study tested if spraying a blue dye called methylene blue during thyroid surgery helps surgeons see and protect important nerves and glands. It involved 136 patients having surgery for a benign thyroid condition. The goal was to see if using the spray reduced the risk of ner…

This study looked back at 300 patients who had their thyroid gland removed. Researchers wanted to see if measuring a hormone (PTH) right after surgery could reliably predict which patients would NOT develop low calcium levels (hypoparathyroidism). The goal was to find a test resu…

This study was a survey to check how much patients and their doctors know about the risks and safe use of the drug NATPARA for hypoparathyroidism. About 200 people, including patients and prescribing doctors, answered true/false questions online, by phone, or on paper. No medicat…

This early study tested several new oral tablet formulations of a hormone (hPTH) used to treat bone diseases like osteoporosis. It involved 45 healthy male volunteers to see how the body absorbs these pills compared to an older oral tablet and a standard injection. The main goal …